Why today is a big day for Pro Medicus shares

Records are being broken by this share on Monday. What's going on?

| More on:
Excited group of friends sitting on sofa watching sports on TV and celebrating.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares have continued their record-breaking run on Monday.

In morning trade, the health imaging technology company's shares have risen over 2% to a record high of $226.79.

This means that its shares are now up a staggering 160% since this time last year.

Why are Pro Medicus shares breaking records today?

Investors have been buying the company's shares this morning following the release of its annual general meeting presentation before the main event.

While that presentation focused a lot of what happened in FY 2024, there was also commentary on the future that appears to have got investors excited.

But let's start with a look at the last financial year. Commenting on the 12 months, Pro Medicus' chair, Peter Kempen, said:

FY2024 was another record year for the company with revenue increasing by 29.3% to $161.5 million and net profit after tax increasing by 36.5% to $82.8 million. The Company continued to be cash flow positive with retained cash and liquid investments increasing from $121.5 million to $155.4 million, after a A$2.77m buyback of shares in February/March, a $US5m investment in cardiac CT AI company Elucid and paying increased dividends.

Pleasingly, Kempen then stated that "the Board anticipates FY25 will be another strong year." He then adds:

The budget for the current financial year has been determined recognising anticipated continuing strong growth, from both existing and new clients. I am pleased to advise that results to date are ahead of budget on a constant currency basis and an Australian dollar basis, despite some volatility in currency markets during the period. We anticipate that the second half of the financial year will be stronger than the first half, as is traditionally the case.

Big future

Also giving Pro Medicus shares a boost is likely to be a part of its presentation which focuses on its total addressable market (TAM).

The company notes that it has a huge TAM in the United States. It highlights that there are 650 million exams performed each year and this is growing by 2% to 3% per annum.

It points out that Pro Medicus' best in class Visage platform is able to address 100% of this TAM from a product perspective and 85% from a commercial perspective.

Whereas at present, its current penetration is just a modest but lucrative 7%. It believes this provides it with a "large addressable runway." Management also sees opportunities to leverage artificial intelligence to drive further growth.

All in all, the future looks bright for Pro Medicus and its shares.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Technology Shares

Here are 2 exciting ASX shares rated as buys

These shares are highly rated by brokers. Let's find out why.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

Is this the decade of the data centre? One ASX 200 stock that could benefit

Let's see why one leading broker thinks this stock could be destined for big things.

Read more »

A human-like robot checks out market performance on a laptop, indicating the rise of AI shares.
Technology Shares

3 top performing ASX AI shares for your watchlist

Have you positioned your portfolio to capitalise on the next tech revolution?

Read more »

A man with a wide, eager smile on his face holds up three fingers.
AI Stocks

3 reasons to buy NextDC shares today

A leading expert forecasts more growth to come for NextDC's rebounding shares.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Technology Shares

Why this $3.9 billion acquisition makes Xero shares a buy today

A leading expert forecasts that Xero’s $3.9 billion investment is about to pay off.

Read more »

Three young people in business attire sit around a desk and discuss.
Small Cap Shares

Tiny tech: 3 ASX small-cap shares with new ratings

Toby Grimm of Baker Young and Peter Day of Sequoia Wealth Management share their new ratings.

Read more »

Smiling young parents with their daughter dream of success.
Technology Shares

Could Life360 shares rise to $37.50?

Bell Potter has given its verdict on this tech stock.

Read more »

Man smiling at a laptop because of a rising share price.
Technology Shares

Investors should put these 2 top ASX tech shares on the watchlist

Looking for growth? These two stocks are delivering.

Read more »